Estrella Immunopharma, Inc. - Warrant (NQ:ESLAW)

0.0812 +0.0286 (+54.37%)

Delayed Quote Updated: 9:30 AM EDT, Oct 19, 2026 Add to My Watchlist

Price and Volume

Volume	500
Open	0.0812
Bid (Size)	0.0525 (100)
Ask (Size)	0.0732 (100)
Prev. Close	0.0526
Today's Range	0.0812 - 0.0812
52wk Range	0.0500 - 0.2400
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Estrella Immunopharma Activates Intermountain Health LDS Hospital as Fifth Clinical Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma

October 14, 2026

From Estrella Immunopharma, Inc.

Via Business Wire

Estrella Immunopharma to Participate in the D. Boral Capital Global Conference

May 05, 2026

From Estrella Immunopharma, Inc.

Via Business Wire

Performance

52-Week Range 66.2% below 52-week high

0.0812

0.0552W Low 0.2452W High

Estrella Immunopharma, Inc. - Warrant (ESLAW) traded between $0.05 and $0.24 over the past 52 weeks and last traded at $0.08, 66.2% below its 52-week high.

Past 12 Months

N/A

+35.3%

+26.9%

-33.0%

+31.8%

+4.2%

1M +$0.02

3M +$0.02

6M -$0.04

YTD +$0.02

1Y +$0.00

ESLAW was +4.2% over the past year, -33.0% over six months, +31.8% year to date.

12 Months vs Market

ESLAW

+4.2%

DIA

+11.2%

SPY

+14.4%

QQQ

+17.6%

IWM

+9.3%

Over the past 12 months ESLAW returned +4.2% versus DIA (Dow) +11.2%, SPY (S&P 500) +14.4%, QQQ (Nasdaq 100) +17.6% and IWM (Russell 2000) +9.3%.

Volume & Liquidity 3.11× 3-mo avg

Today 500 3-mo avg 161.0

10.0

161.0

1.2K

YTD

1.9K

4.9K

ESLAW most recently traded 500 shares against a 3-month average daily volume of 161.0.

More News

Estrella Immunopharma, Inc. (NASDAQ: ESLA) Receives Initiating Coverage with a Valuation of $12.00/Share from Zacks Small-Cap Research

March 23, 2026

From Estrella Immunopharma, Inc.

Via Business Wire

Estrella Immunopharma Presents Promising Updated Data on EB103 in Oral Presentation at the 2026 Tandem Meetings of ASTCT® & CIBMTR®

February 09, 2026

From Estrella Immunopharma, Inc.

Via Business Wire

Estrella Immunopharma Announces Closing of $8.0 Million Registered Direct Offering and Concurrent Private Placement

January 06, 2026

From Estrella Immunopharma, Inc.

Via Business Wire

Estrella Immunopharma Completes First Dose Cohort in STARLIGHT-1 Trial and Receives Approval to Initiate Higher Dose Cohort

February 21, 2025

From Estrella Immunopharma

Via Business Wire

Estrella Immunopharma, Inc. (NASDAQ: ESLA; ESLAW) Receives Buy Rating with a 12-Month Price Target of $16.00 from D. Boral Capital

February 19, 2025

From Estrella Immunopharma, Inc.

Via Business Wire

Estrella Immunopharma Achieves Complete Response in First Patient Treated with CD19- Redirected ARTEMIS® T-cells

September 27, 2024

From Estrella Immunopharma, Inc.

Via Business Wire

Estrella Immunopharma Announces Appointment of Hong Zhang as Chairperson and Board Member

August 14, 2024

From Estrella Immunopharma, Inc.

Via Business Wire

Frequently Asked Questions

Is Estrella Immunopharma, Inc. - Warrant publicly traded?

Yes, Estrella Immunopharma, Inc. - Warrant is publicly traded.

What exchange does Estrella Immunopharma, Inc. - Warrant trade on?

Estrella Immunopharma, Inc. - Warrant trades on the Nasdaq Stock Market

What is the ticker symbol for Estrella Immunopharma, Inc. - Warrant?

The ticker symbol for Estrella Immunopharma, Inc. - Warrant is ESLAW on the Nasdaq Stock Market

What is the current price of Estrella Immunopharma, Inc. - Warrant?

The current price of Estrella Immunopharma, Inc. - Warrant is 0.0812

When was Estrella Immunopharma, Inc. - Warrant last traded?

The last trade of Estrella Immunopharma, Inc. - Warrant was at 10/19/26 09:30 AM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.